Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jeremy Eisele"'
Autor:
Mark A. Schroeder, Jaebok Choi, Himachandana Atluri, Jordan Atkins, Melinda Harding, Jeremy Eisele, Feng Gao, Ramzi Abboud, Camille Abboud, Amanda F. Cashen, Matthew Christopher, Todd A. Fehniger, Francesca Ferraro, Armin Ghobadi, Meagan A. Jacoby, Iskra Pusic, Keith E Stockerl-Goldstein, Geoffrey L. Uy, Ravi Vij, Matthew J Walter, Peter Westervelt, John F. DiPersio
Publikováno v:
Blood. 140:1875-1876
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2272c5362133c416b9519416cac1794b
https://doi.org/10.1182/blood-2022-157214
https://doi.org/10.1182/blood-2022-157214
Autor:
Melissa M. Berrien-Elliott, Jennifer A. Foltz, David A. Russler-Germain, Carly C. Neal, Jennifer Tran, Margery Gang, Pamela Wong, Bryan Fisk, Celia C. Cubitt, Nancy D. Marin, Alice Y. Zhou, Miriam T. Jacobs, Mark Foster, Timothy Schappe, Ethan McClain, Samantha Kersting-Schadek, Sweta Desai, Patrick Pence, Michelle Becker-Hapak, Jeremy Eisele, Matthew Mosior, Lynne Marsala, Obi L. Griffith, Malachi Griffith, Saad M. Khan, David H. Spencer, John F. DiPersio, Rizwan Romee, Geoffrey L. Uy, Camille N. Abboud, Armin Ghobadi, Peter Westervelt, Keith Stockerl-Goldstein, Mark A. Schroeder, Fei Wan, Wen-Rong Lie, Patrick Soon-Shiong, Allegra A. Petti, Amanda F. Cashen, Todd A. Fehniger
Publikováno v:
Sci Transl Med
Natural killer (NK) cells are innate lymphoid cells that eliminate cancer cells, produce cytokines, and are being investigated as a nascent cellular immunotherapy. Impaired NK cell function, expansion, and persistence remain key challenges for optima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d5b150b9fb46a2a7f0c16ecb5e95ee
https://europepmc.org/articles/PMC9210521/
https://europepmc.org/articles/PMC9210521/
Autor:
Jeffrey J. Bednarski, Clare Zimmerman, Melissa M. Berrien-Elliott, Jennifer A. Foltz, Michelle Becker-Hapak, Carly C. Neal, Mark Foster, Timothy Schappe, Ethan McClain, Patrick P. Pence, Sweta Desai, Samantha Kersting-Schadek, Pamela Wong, David A. Russler-Germain, Bryan Fisk, Wen-Rong Lie, Jeremy Eisele, Stephanie Hyde, Sima T. Bhatt, Obi L. Griffith, Malachi Griffith, Allegra A. Petti, Amanda F. Cashen, Todd A. Fehniger
Publikováno v:
Blood. 139(11)
Pediatric and young adult (YA) patients with acute myeloid leukemia (AML) who relapse after allogeneic hematopoietic cell transplantation (HCT) have an extremely poor prognosis. Standard salvage chemotherapy and donor lymphocyte infusions (DLIs) have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9efaab635be9bfc8a2aaaeb83827448
https://pubmed.ncbi.nlm.nih.gov/35298605
https://pubmed.ncbi.nlm.nih.gov/35298605
Autor:
Jeremy Eisele, Michael P. Rettig, Keith Stockerl-Goldstein, Iskra Pusic, Camille N. Abboud, Mark A. Schroeder, Feng Gao, Leah Gehrs, Armin Ghobadi, Ramzi Abboud, Matthew J. Christopher, Peter Westervelt, John F. DiPersio, Geoffrey L. Uy, Meagan A. Jacoby, Nichols Wallace, Amanda F. Cashen
Publikováno v:
Transplantation and Cellular Therapy. 28:S298-S299
Introduction: Haploidentical peripheral blood allogeneic hematopoietic cell transplantation (PB haplo-HCT) can be complicated by graft-versus-host disease (GVHD) and cytokine release syndrome (CRS). Acute GVHD rates are higher with PB grafts compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd17dca2dd0eb113d6040ade911080ba
https://doi.org/10.1016/s2666-6367(22)00546-2
https://doi.org/10.1016/s2666-6367(22)00546-2